Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 2808 entries
Sorted by: Best Match Show Resources per page
Antidepressant and specific norepinephrine reuptake inhibitor treatments

interventions

[No authors listed]
GSID: 537Z4Aw7syQJ
TJ Spencer, J Biederman, T Wilens - Attention-deficit hyperactvity …, 2006 - academia.edu

Stimulants (see Chapter 17, this volume) are very effective in the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD); however, it is estimated that at least 30% of affected …

Nanocapillary electrophoretic electrochemical chip: towards analysis of biochemicals released by single cells.

Interface focus

Wu RG, Yang CS, Cheing CC, Tseng FG.
PMID: 23050079
Interface Focus. 2011 Oct 06;1(5):744-53. doi: 10.1098/rsfs.2011.0049. Epub 2011 Jul 14.

A novel nanocapillary electrophoretic electrochemical (Nano-CEEC) chip has been developed to demonstrate the possibility of zeptomole-level detection of neurotransmitters released from single living cells. The chip integrates three subunits to collect and concentrate scarce neurotransmitters released from single PC-12...

Cite
Wu RG, Yang CS, Cheing CC, et al. Nanocapillary electrophoretic electrochemical chip: towards analysis of biochemicals released by single cells. Interface Focus. 2011;1(5):744-53doi: 10.1098/rsfs.2011.0049.
Wu, R. G., Yang, C. S., Cheing, C. C., & Tseng, F. G. (2011). Nanocapillary electrophoretic electrochemical chip: towards analysis of biochemicals released by single cells. Interface focus, 1(5), 744-53. https://doi.org/10.1098/rsfs.2011.0049
Wu, Ren-Guei, et al. "Nanocapillary electrophoretic electrochemical chip: towards analysis of biochemicals released by single cells." Interface focus vol. 1,5 (2011): 744-53. doi: https://doi.org/10.1098/rsfs.2011.0049
Wu RG, Yang CS, Cheing CC, Tseng FG. Nanocapillary electrophoretic electrochemical chip: towards analysis of biochemicals released by single cells. Interface Focus. 2011 Oct 06;1(5):744-53. doi: 10.1098/rsfs.2011.0049. Epub 2011 Jul 14. PMID: 23050079; PMCID: PMC3262288.
Copy Download .nbib Format: NLM
Paraganglioma in a young patient with asymptomatic severe hypertension: a case report and review of the literature.

Hippokratia

Koumaras Ch, Anagnostis P, Tzimou M, Giavanidis I, Gossios T, Antoniadis A, Athyros VG, Karagiannis A.
PMID: 21311646
Hippokratia. 2010 Oct;14(4):300-2.

We present a case of a 19-year old woman who was admitted to our department with a recently, and incidentally, diagnosed severe hypertension [220/140 mmHg systolic/diastolic blood pressure (BP)]. The patient was asymptomatic. The laboratory investigation demonstrated both elevated...

Cite
Koumaras Ch, Anagnostis P, Tzimou M, et al. Paraganglioma in a young patient with asymptomatic severe hypertension: a case report and review of the literature. Hippokratia. 2010;14(4):300-2
Koumaras, C. h., Anagnostis, P., Tzimou, M., Giavanidis, I., Gossios, T., Antoniadis, A., Athyros, V. G., & Karagiannis, A. (2010). Paraganglioma in a young patient with asymptomatic severe hypertension: a case report and review of the literature. Hippokratia, 14(4), 300-2.
Koumaras, Ch, et al. "Paraganglioma in a young patient with asymptomatic severe hypertension: a case report and review of the literature." Hippokratia vol. 14,4 (2010): 300-2.
Koumaras Ch, Anagnostis P, Tzimou M, Giavanidis I, Gossios T, Antoniadis A, Athyros VG, Karagiannis A. Paraganglioma in a young patient with asymptomatic severe hypertension: a case report and review of the literature. Hippokratia. 2010 Oct;14(4):300-2. PMID: 21311646; PMCID: PMC3031332.
Copy Download .nbib Format: NLM
Effects of α2A Adrenoceptors on Norepinephrine Secretion from the Locus Coeruleus during Chronic Stress-Induced Depression.

Frontiers in neuroscience

Wang B, Wang Y, Wu Q, Huang HP, Li S.
PMID: 28507504
Front Neurosci. 2017 May 01;11:243. doi: 10.3389/fnins.2017.00243. eCollection 2017.

Chronic stressors can often lead to the development of psychological disorders, such as depression and anxiety. The locus coeruleus (LC) is a stress sensitive brain region located in the pons, with noradrenergic neurons that project to the hypothalamus, especially...

Cite
Wang B, Wang Y, Wu Q, et al. Effects of α2A Adrenoceptors on Norepinephrine Secretion from the Locus Coeruleus during Chronic Stress-Induced Depression. Front Neurosci. 2017;11:243doi: 10.3389/fnins.2017.00243.
Wang, B., Wang, Y., Wu, Q., Huang, H. P., & Li, S. (2017). Effects of α2A Adrenoceptors on Norepinephrine Secretion from the Locus Coeruleus during Chronic Stress-Induced Depression. Frontiers in neuroscience, 11243. https://doi.org/10.3389/fnins.2017.00243
Wang, Bin, et al. "Effects of α2A Adrenoceptors on Norepinephrine Secretion from the Locus Coeruleus during Chronic Stress-Induced Depression." Frontiers in neuroscience vol. 11 (2017): 243. doi: https://doi.org/10.3389/fnins.2017.00243
Wang B, Wang Y, Wu Q, Huang HP, Li S. Effects of α2A Adrenoceptors on Norepinephrine Secretion from the Locus Coeruleus during Chronic Stress-Induced Depression. Front Neurosci. 2017 May 01;11:243. doi: 10.3389/fnins.2017.00243. eCollection 2017. PMID: 28507504; PMCID: PMC5410613.
Copy Download .nbib Format: NLM
Takotsubo cardiomyopathy after administration of norepinephrine.

Proceedings (Baylor University. Medical Center)

Sherif K, Sehli S, Jenkins LA.
PMID: 27034556
Proc (Bayl Univ Med Cent). 2016 Apr;29(2):166-7. doi: 10.1080/08998280.2016.11929402.

Stress-induced cardiomyopathy is a syndrome of transient cardiac dysfunction with no clear pathophysiology. It is thought to be secondary to catecholamine surge. The mechanism by which catecholamine can induce transient cardiac dysfunction is unknown. We present a case of...

Cite
Sherif K, Sehli S, Jenkins LA. Takotsubo cardiomyopathy after administration of norepinephrine. Proc (Bayl Univ Med Cent). 2016;29(2):166-7doi: 10.1080/08998280.2016.11929402.
Sherif, K., Sehli, S., & Jenkins, L. A. (2016). Takotsubo cardiomyopathy after administration of norepinephrine. Proceedings (Baylor University. Medical Center), 29(2), 166-7. https://doi.org/10.1080/08998280.2016.11929402
Sherif, Khaled, et al. "Takotsubo cardiomyopathy after administration of norepinephrine." Proceedings (Baylor University. Medical Center) vol. 29,2 (2016): 166-7. doi: https://doi.org/10.1080/08998280.2016.11929402
Sherif K, Sehli S, Jenkins LA. Takotsubo cardiomyopathy after administration of norepinephrine. Proc (Bayl Univ Med Cent). 2016 Apr;29(2):166-7. doi: 10.1080/08998280.2016.11929402. PMID: 27034556; PMCID: PMC4790558.
Copy Download .nbib Format: NLM
Ca(2+)-Currents in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Effects of Two Different Culture Conditions.

Frontiers in pharmacology

Uzun AU, Mannhardt I, Breckwoldt K, Horváth A, Johannsen SS, Hansen A, Eschenhagen T, Christ T.
PMID: 27672365
Front Pharmacol. 2016 Sep 12;7:300. doi: 10.3389/fphar.2016.00300. eCollection 2016.

Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM) provide a unique opportunity to study human heart physiology and pharmacology and repair injured hearts. The suitability of hiPSC-CM critically depends on how closely they share physiological properties of human adult cardiomyocytes...

Cite
Uzun AU, Mannhardt I, Breckwoldt K, et al. Ca(2+)-Currents in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Effects of Two Different Culture Conditions. Front Pharmacol. 2016;7:300doi: 10.3389/fphar.2016.00300.
Uzun, A. U., Mannhardt, I., Breckwoldt, K., Horváth, A., Johannsen, S. S., Hansen, A., Eschenhagen, T., & Christ, T. (2016). Ca(2+)-Currents in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Effects of Two Different Culture Conditions. Frontiers in pharmacology, 7300. https://doi.org/10.3389/fphar.2016.00300
Uzun, Ahmet U, et al. "Ca(2+)-Currents in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Effects of Two Different Culture Conditions." Frontiers in pharmacology vol. 7 (2016): 300. doi: https://doi.org/10.3389/fphar.2016.00300
Uzun AU, Mannhardt I, Breckwoldt K, Horváth A, Johannsen SS, Hansen A, Eschenhagen T, Christ T. Ca(2+)-Currents in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Effects of Two Different Culture Conditions. Front Pharmacol. 2016 Sep 12;7:300. doi: 10.3389/fphar.2016.00300. eCollection 2016. PMID: 27672365; PMCID: PMC5018497.
Copy Download .nbib Format: NLM
New developments in the management of narcolepsy.

Nature and science of sleep

Abad VC, Guilleminault C.
PMID: 28424564
Nat Sci Sleep. 2017 Mar 03;9:39-57. doi: 10.2147/NSS.S103467. eCollection 2017.

Narcolepsy is a life-long, underrecognized sleep disorder that affects 0.02%-0.18% of the US and Western European populations. Genetic predisposition is suspected because of narcolepsy's strong association with HLA DQB1*06-02, and genome-wide association studies have identified polymorphisms in T-cell receptor...

Cite
Abad VC, Guilleminault C. New developments in the management of narcolepsy. Nat Sci Sleep. 2017;9:39-57doi: 10.2147/NSS.S103467.
Abad, V. C., & Guilleminault, C. (2017). New developments in the management of narcolepsy. Nature and science of sleep, 939-57. https://doi.org/10.2147/NSS.S103467
Abad, Vivien C, and Guilleminault, Christian. "New developments in the management of narcolepsy." Nature and science of sleep vol. 9 (2017): 39-57. doi: https://doi.org/10.2147/NSS.S103467
Abad VC, Guilleminault C. New developments in the management of narcolepsy. Nat Sci Sleep. 2017 Mar 03;9:39-57. doi: 10.2147/NSS.S103467. eCollection 2017. PMID: 28424564; PMCID: PMC5344488.
Copy Download .nbib Format: NLM
Pharmacologic Therapy for Posttraumatic Stress Disorder: Review of Prescriptions and Potential Drug-Drug Interactions in a Military Cohort.

The primary care companion for CNS disorders

Jablonski KL, Devore MD, Ryan MA, Streeter EL, Tolentino JC, Klinski AA, Bahlawan N.
PMID: 27057415
Prim Care Companion CNS Disord. 2015 Dec 03;17(6). doi: 10.4088/PCC.15m01843. eCollection 2015.

OBJECTIVE: To describe outpatient prescription treatment for active-duty military members with posttraumatic stress disorder (PTSD). Medical records were screened for drug-drug interactions with PTSD-related medications and for adverse drug events.METHOD: A retrospective chart review was conducted of the medical...

Cite
Jablonski KL, Devore MD, Ryan MA, et al. Pharmacologic Therapy for Posttraumatic Stress Disorder: Review of Prescriptions and Potential Drug-Drug Interactions in a Military Cohort. Prim Care Companion CNS Disord. 2015;17(6)doi: 10.4088/PCC.15m01843.
Jablonski, K. L., Devore, M. D., Ryan, M. A., Streeter, E. L., Tolentino, J. C., Klinski, A. A., & Bahlawan, N. (2015). Pharmacologic Therapy for Posttraumatic Stress Disorder: Review of Prescriptions and Potential Drug-Drug Interactions in a Military Cohort. The primary care companion for CNS disorders, 17(6), . https://doi.org/10.4088/PCC.15m01843
Jablonski, Kara L, et al. "Pharmacologic Therapy for Posttraumatic Stress Disorder: Review of Prescriptions and Potential Drug-Drug Interactions in a Military Cohort." The primary care companion for CNS disorders vol. 17,6 (2015). doi: https://doi.org/10.4088/PCC.15m01843
Jablonski KL, Devore MD, Ryan MA, Streeter EL, Tolentino JC, Klinski AA, Bahlawan N. Pharmacologic Therapy for Posttraumatic Stress Disorder: Review of Prescriptions and Potential Drug-Drug Interactions in a Military Cohort. Prim Care Companion CNS Disord. 2015 Dec 03;17(6). doi: 10.4088/PCC.15m01843. eCollection 2015. PMID: 27057415; PMCID: PMC4805416.
Copy Download .nbib Format: NLM
[Craving as a core symptom in substance use disorders: epidemiology, neurobiological substrates and clinical relevance].

Sante mentale au Quebec

Morissette A, Ouellet-Plamondon C, Jutras-Aswad D.
PMID: 25590542
Sante Ment Que. Fall 2014;39(2):21-37.

OBJECTIVE: Observed by physicians and often reported by patients, craving is a core symptom of addiction, although not well defined nor understood completely. In the last several years, functional imaging as well as the measurement of different biological substrates...

Cite
Morissette A, Ouellet-Plamondon C, Jutras-Aswad D. Le craving comme symptôme central de la toxicomanie : de ses fondements neurobiologiques à sa pertinence clinique. [Craving as a core symptom in substance use disorders: epidemiology, neurobiological substrates and clinical relevance]. Sante Ment Que. 0;39(2):21-37
Morissette, A., Ouellet-Plamondon, C., & Jutras-Aswad, D. (0). Le craving comme symptôme central de la toxicomanie : de ses fondements neurobiologiques à sa pertinence clinique. [Craving as a core symptom in substance use disorders: epidemiology, neurobiological substrates and clinical relevance]. Sante mentale au Quebec, 39(2), 21-37.
Morissette, Audrey, et al. "Le craving comme symptôme central de la toxicomanie : de ses fondements neurobiologiques à sa pertinence clinique." [Craving as a core symptom in substance use disorders: epidemiology, neurobiological substrates and clinical relevance]. Sante mentale au Quebec vol. 39,2 (0): 21-37.
Morissette A, Ouellet-Plamondon C, Jutras-Aswad D. Le craving comme symptôme central de la toxicomanie : de ses fondements neurobiologiques à sa pertinence clinique. [Craving as a core symptom in substance use disorders: epidemiology, neurobiological substrates and clinical relevance]. Sante Ment Que. Fall 2014;39(2):21-37. French. PMID: 25590542.
Copy Download .nbib Format: NLM
Tapentadol extended release in the management of peripheral diabetic neuropathic pain.

Therapeutics and clinical risk management

Vadivelu N, Kai A, Maslin B, Kodumudi G, Legler A, Berger JM.
PMID: 25609974
Ther Clin Risk Manag. 2015 Jan 14;11:95-105. doi: 10.2147/TCRM.S32193. eCollection 2015.

Tapentadol, a μ-opioid agonist and norepinephrine reuptake inhibitor, has been found to be an effective medication for a wide variety of chronic pain conditions, including back pain, cancer-related pain, and arthritic pain. It has also been found to have...

Cite
Vadivelu N, Kai A, Maslin B, et al. Tapentadol extended release in the management of peripheral diabetic neuropathic pain. Ther Clin Risk Manag. 2015;11:95-105doi: 10.2147/TCRM.S32193.
Vadivelu, N., Kai, A., Maslin, B., Kodumudi, G., Legler, A., & Berger, J. M. (2015). Tapentadol extended release in the management of peripheral diabetic neuropathic pain. Therapeutics and clinical risk management, 1195-105. https://doi.org/10.2147/TCRM.S32193
Vadivelu, Nalini, et al. "Tapentadol extended release in the management of peripheral diabetic neuropathic pain." Therapeutics and clinical risk management vol. 11 (2015): 95-105. doi: https://doi.org/10.2147/TCRM.S32193
Vadivelu N, Kai A, Maslin B, Kodumudi G, Legler A, Berger JM. Tapentadol extended release in the management of peripheral diabetic neuropathic pain. Ther Clin Risk Manag. 2015 Jan 14;11:95-105. doi: 10.2147/TCRM.S32193. eCollection 2015. PMID: 25609974; PMCID: PMC4298300.
Copy Download .nbib Format: NLM
Impact of Maternal Melatonin Suppression on Amount and Functionality of Brown Adipose Tissue (BAT) in the Newborn Sheep.

Frontiers in endocrinology

Seron-Ferre M, Reynolds H, Mendez NA, Mondaca M, Valenzuela F, Ebensperger R, Valenzuela GJ, Herrera EA, Llanos AJ, Torres-Farfan C.
PMID: 25610428
Front Endocrinol (Lausanne). 2015 Jan 06;5:232. doi: 10.3389/fendo.2014.00232. eCollection 2014.

In human and sheep newborns, brown adipose tissue (BAT) accrued during fetal development is used for newborn thermogenesis. Here, we explored the role of maternal melatonin during gestation on the amount and functionality of BAT in the neonate. We...

Cite
Seron-Ferre M, Reynolds H, Mendez NA, et al. Impact of Maternal Melatonin Suppression on Amount and Functionality of Brown Adipose Tissue (BAT) in the Newborn Sheep. Front Endocrinol (Lausanne). 2015;5:232doi: 10.3389/fendo.2014.00232.
Seron-Ferre, M., Reynolds, H., Mendez, N. A., Mondaca, M., Valenzuela, F., Ebensperger, R., Valenzuela, G. J., Herrera, E. A., Llanos, A. J., & Torres-Farfan, C. (2014). Impact of Maternal Melatonin Suppression on Amount and Functionality of Brown Adipose Tissue (BAT) in the Newborn Sheep. Frontiers in endocrinology, 5232. https://doi.org/10.3389/fendo.2014.00232
Seron-Ferre, Maria, et al. "Impact of Maternal Melatonin Suppression on Amount and Functionality of Brown Adipose Tissue (BAT) in the Newborn Sheep." Frontiers in endocrinology vol. 5 (2014): 232. doi: https://doi.org/10.3389/fendo.2014.00232
Seron-Ferre M, Reynolds H, Mendez NA, Mondaca M, Valenzuela F, Ebensperger R, Valenzuela GJ, Herrera EA, Llanos AJ, Torres-Farfan C. Impact of Maternal Melatonin Suppression on Amount and Functionality of Brown Adipose Tissue (BAT) in the Newborn Sheep. Front Endocrinol (Lausanne). 2015 Jan 06;5:232. doi: 10.3389/fendo.2014.00232. eCollection 2014. PMID: 25610428; PMCID: PMC4285176.
Copy Download .nbib Format: NLM
Methylene blue treatment for cytokine release syndrome-associated vasoplegia following a renal transplant with rATG infusion: A case report and literature review.

Experimental and therapeutic medicine

Denny JT, Burr AT, Balzer F, Tse JT, Denny JE, Chyu D.
PMID: 26136914
Exp Ther Med. 2015 May;9(5):1915-1920. doi: 10.3892/etm.2015.2349. Epub 2015 Mar 12.

Rabbit anti-thymocyte globulin (rATG) is an infusion of polyclonal rabbit-derived antibodies against human thymocyte markers, which can be used to prevent and treat acute rejection following organ transplantation. However, the product monograph issued by the manufacturer (Sanofi Canada) reports...

Cite
Denny JT, Burr AT, Balzer F, et al. Methylene blue treatment for cytokine release syndrome-associated vasoplegia following a renal transplant with rATG infusion: A case report and literature review. Exp Ther Med. 2015;9(5):1915-1920doi: 10.3892/etm.2015.2349.
Denny, J. T., Burr, A. T., Balzer, F., Tse, J. T., Denny, J. E., & Chyu, D. (2015). Methylene blue treatment for cytokine release syndrome-associated vasoplegia following a renal transplant with rATG infusion: A case report and literature review. Experimental and therapeutic medicine, 9(5), 1915-1920. https://doi.org/10.3892/etm.2015.2349
Denny, John T, et al. "Methylene blue treatment for cytokine release syndrome-associated vasoplegia following a renal transplant with rATG infusion: A case report and literature review." Experimental and therapeutic medicine vol. 9,5 (2015): 1915-1920. doi: https://doi.org/10.3892/etm.2015.2349
Denny JT, Burr AT, Balzer F, Tse JT, Denny JE, Chyu D. Methylene blue treatment for cytokine release syndrome-associated vasoplegia following a renal transplant with rATG infusion: A case report and literature review. Exp Ther Med. 2015 May;9(5):1915-1920. doi: 10.3892/etm.2015.2349. Epub 2015 Mar 12. PMID: 26136914; PMCID: PMC4471690.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 2808 entries